DiFabio Andrea
SEC CIK 1692506 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | CLO | 7,301 | — | $230.8K | 4 | 2026-03-09 | 2026-03-13 |
Most active insiders at XENE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORTIMER IAN | Pres, CEO, INTERIM CFO, Dir | — | $21.30M |
| 2 | KENNEY CHRISTOPHER JOHN | Chief Medical Off | — | $670.3K |
| 3 | GANNON STEVEN | Dir | — | $640.6K |
| 4 | DiFabio Andrea | CLO | — | $230.8K |
| 5 | PATOU GARY | Dir | — | $70.3K |
| 6 | Cannon Gillian | Dir | — | $63.2K |
| 7 | GAROFALO ELIZABETH A. | Dir | — | — |
| 8 | Gover Justin D. | Dir | — | — |
| 9 | Svoronos Dawn | Dir | — | — |
| 10 | Machado Patrick | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-03-13 | 2026-03-12 | XENE | Xenon Pharmaceuticals Inc. | DiFabio Andrea | CLO | M - OptEx | — | +3,750 | 8,643 | +77% | — |
| DT | 2026-03-13 | 2026-03-13 | XENE | Xenon Pharmaceuticals Inc. | DiFabio Andrea | CLO | S - Sale+OE | $55.23 | -1,342 | 7,301 | -16% | -$74.1K |
| DT | 2026-03-11 | 2026-03-09 | XENE | Xenon Pharmaceuticals Inc. | DiFabio Andrea | CLO | M - OptEx | — | +7,500 | 7,500 | New | — |
| DT | 2026-03-11 | 2026-03-10 | XENE | Xenon Pharmaceuticals Inc. | DiFabio Andrea | CLO | S - Sale+OE | $60.11 | -2,607 | 4,893 | -35% | -$156.7K |
Purchase Sale Sale after option exercise All abbreviations